Brent Saunders; Chairman of the Board, Chief Executive Officer; Bausch & Lomb Corp Sam Eldessouky; Chief Financial Officer, Executive Vice President; Bausch & Lomb Corp Thank you. Good morning, ...

The first-line laser treatment for glaucoma and ocular hypertension will be unveiled at the 2025 American Glaucoma Society ...

Hydrophilic and hydrophobic IOLs demonstrate similar visual outcomes and inflammatory responses in patients with and without uveitis.

Surgeons need to understand the personality traits of patients with presbyopia to set proper expectations for multifocal IOL ...

Bausch & Lomb is one of the largest vision care companies in the US. Bausch spun off from its former parent company, Bausch Health, in 2022 and it now operates in three segments: vision care, surgical ...

The TECNIS PureSee™ IOL features a purely refractive design that delivers uninterrupted, high-quality, vision with high ...

THE Philippine Health Insurance Corp. (PhilHealth) has announced a significant increase in its benefits for Extracapsular ...

Eyesight differs from person to person due to several factors, including aging, genetics, and lifestyle choices. Human-led ...

With its purely refractive design, the TECNIS PureSee IOL ensures surgeons’ ease of use in providing high tolerance to ...

More than half of U.S. adults 80 and older either have cataracts or have had surgery to remove them [1]. With cataracts, the ...

Light adjustable lenses have strong visual and refractive outcomes in patients who have previously undergone radial keratotomy.

Ophthalmologists must embrace corneal diagnostics to select the proper patient for premium multifocal IOLs, according to a ...